Improvement of metabolism among obese breast cancer survivors in differing weight loss regimens

Obesity Research

Volumn 12, Issue 2, 2004, Pages 306-312

  Jen, K L Catherine ^a   Djuric, Zora ^b   DiLaura, Nora M ^b   Buison, Anne ^a   Redd, Jennifer N ^b   Maranci, Vera ^b   Hryniuk, William M ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Breast cancer survivors; Insulin sensitivity; Leptin; Metabolic parameters; Weight loss regimens

Indexed keywords

INSULIN; LEPTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DIET THERAPY; DIETETICS; FEMALE; HUMAN; LOW CALORY DIET; METABOLISM; MIDDLE AGED; OBESITY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SELF HELP; SURVIVOR; TUMOR RECURRENCE; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; COUNSELING; DIET, REDUCING; DIETETICS; FEMALE; HUMANS; INSULIN; LEPTIN; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBESITY; SELF-HELP GROUPS; SURVIVORS; WEIGHT LOSS;

EID: 4644356592     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2004.38     Document Type: Article

References (44)

1. Mokdad A, Bowman B, Ford E, Vinicor F, Marks J, Koplan J. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-200.
2. Pi-Sunyer F. Medical hazards of obesity. Ann Intern Med. 1993;119:655-60.
3. Tuomilehto J, Lindstrom J, Eriksson J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50.
4. Ross R, Dagnone D, Jones P, et al. Reduction in obesity and related comorbid conditions after diet-induced wieght loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med. 2000;133:92-103.
5. Lean M. Obesity - what are the current treatment options? Exp Clin Endocrinol Diabetes. 1998;106(Suppl 2):22-6.
6. Sarlio-Lahteenkorva S, Rissanen AJ. A descriptive study of weight loss maintenance: 6 and 15 years follow-up of initially overweight adults. Int J Obes Relat Metab Disord. 2000;24:116-25.
7. Drenick E, Johnson D. Weight reduction by fasting and semistarvation in morbid obesity: long term follow-up. Int J Obes. 1978;2:25-34.
8. Crawford D, Jeffery R, French S. Can anyone successfully control their weight? Findings of a three year community-based study of men and women. Int J Obes Relat Metab Disord. 2000;24:1107-10.
9. La Vecchia C, Negri E, Franceschi S, et al. Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer. 1997;75:441-4.
10. Ballard-Barbash R, Swanson C. Body weight: an estimation of risk for breast and endometrial cancers. Am J Clin Nutr 1996;63(Suppl):437S-441S.
11. Ballard-Barbash R. Anthropometry and breast cancer. Cancer. 1994;74:1090-100.
12. De Waard F, Ramlau R, Mulders Y, de Vries T, van Waveren S. A feasibility study on weight reduction in obese postmenopausal breast cancer patients. Eur J Cancer Prev. 1993;2:233-8.
13. Goodwin P, Esplen M, Butler K, et al. Multidisciplinary weight management in locoregional breast cancer: results of a phase II study. Breast Cancer Res Treat. 1998;48:53-64.
14. Goodwin P, Ennis M, Pritchard K, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002;20:42-51.
15. Song E, Banerjee M, Du W, Hryniuk W. Diabetes but not obesity is a prognostic factor for disease free survival (DFS) in women with stage I, II and III breast carcinoma receiving Tamoxifen. Breast Cancer Res Treat. 2000;64:40.
16. Djuric Z, DiLaura N, Jenkins I, et al. Combining weight-loss counseling with Weight Watchers Plan for obese breast cancer survivors. Obes Res. 2002;10:657-65.
17. Matthews D, Hosker J, Rudenski ABA, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
18. Stoll B. Nutrition and breast cancer risk: can an effect via insulin resistance be demonstrated? Breast Cancer Res Treat. 1996;38:239-46.
19. Mavri A, Stegnar M, Sabovic M. Do baseline serum leptin levels predict weight regain after dieting in obese women? Diabetes Obes Metab. 2001;3:293-6.
20. Chlebowski R, Aiello E, McTieman A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20:1128-43.
21. Friedenreich C. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev. 2001;10:15-32.
22. Daling J, Malone K, Doody D, Johnson L, Gralow J, Porter P. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer. 2001;92:720-9.
23. Ray G, Husain S. Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem. 2001;34:71-6.
24. Qi X, Zhang A, Wu G, Pang W. The association between breast cancer and diet and other factors. Asia Pac J Public Health. 1994;7:98-104.
25. Gaard M, Tretli S, Urdal P. Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women. Cancer Causes Control. 1994;5:501-9.
26. Hoyer A, Engholm G. Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women. Cancer Causes Control. 1992;3:403-8.
27. Friday K. Aggressive lipid management for cardiovascular prevention: evidence from clinical trials. Exp Biol Med. 2003; 228:769-78.
28. Schreier L, Berg G, Basilio F, Lopez G, Etkin A, Wikinski R. Lipoprotein alterations, abdominal fat distribution and breast cancer. Biochem Mol Biol Int. 1999;47:681-90.
29. Fiorenza A, Branchi A, Sommariva D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res. 2000;30:141-5.
30. Kokoglu E, Karaarslan I, Karaarslan H, Baloglu H. Alterations of serum lipids and lipoproteins in breast cancer. Cancer Lett. 1994;82:175-8.
31. Moysich K, Freudenheim J, Baker J, et al. Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk. Mol Carcinog. 2000;27:2-9.
32. Moorman P, Hulka B, Hiatt R, et al. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev. 1998;7:483-8.
33. Borrelli R, del Sordo G, De Filippo E, Contaldo F, Parisi V, Beneduce G. High serum HDL-cholesterol in pre- and post-menopausal women with breast cancer in southern Italy. Adv Exp Med Biol. 1993;348:149-53.
34. Mastroianni A, Bellati C, Facchetti G, Oldani S, Franzini C, Berrino F. Increased plasma HDL-cholesterol and apo A-1 in breast cancer patients undergoing adjuvant tamoxifen therapy. Clin Biochem. 2000;33:513-6.
35. Rzymowska J. Effect of cytotoxic chemotherapy on serum lipid levels in breast cancer patients. Pathobiology. 1999;67:129-32.
36. Demark-Wahnefried W, Peterson B, Winer E, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2001;19:2381-9.
37. Johansson G, Wikman A, Ahren A, Hallmans G, Johansson I. Underreporting of energy intake in repeated 24-hour recalls related to gender, age, weight status, day of interview, educational level, reported food intake, smoking habits and area of living. Public Health Nutr. 2001;4:919-27.
38. Johnson R, Soultanakis R, Natthews D. Literacy and body fatness are associated with underreporting of energy intake in US low-income women using the multiple-pass 24-hour recall: a doubly labeled water study. J Am Diet Assoc. 1998;98:1136-40.
39. Boden W. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol. 2000;86:19L-22L.
40. Bouloumie A, Drexler H, Lafontan M, Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res. 1998; 83:1059-66.
41. Sierra-Honigmann M, Nath A, Murakami C, et al. Biological action of leptin as an angiogenic factor. Science. 1998; 281:1683-6.
42. Dieudonne M, Machinal-Quelin F, Serazin-Leroy V, Leneveu M, Pecquery R, Giudicelli Y. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun. 2002;293:622-8.
43. Tessitore L, Vizio B, Jenkins O, et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med. 2000;5: 421-6.
44. Caro J, Sinha M, Kolaczynski J, Zhang P, Considine R. Leptin: the tale of an obesity gene. Diabetes. 1996;45:1455-62.